Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Immunology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Ulcerative Colitis Clinical Trials

A listing of Ulcerative Colitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (246) clinical trials

This Ulcerative Colitis Registry study is for Patients with Moderately to Severely Active Ulcerative Colitis and currently taking HUMIRA (Adalimumab) therapy.

Phase N/A

Wake Research Associates is currently enrolling a research study, testing standard doses of an already-approved medicine versus a higher dose in individuals with moderate to severe ulcerative colitis.

Phase N/A

A Phase 2, randomized, placebo-controlled, multi-center study to investigate the efficacy and safety of Apremilast (CC-10004) for the treatment of subjects with active ulcerative colitis

Phase

If you’re suffering from ulcerative colitis, you're invited to see if you may qualify for the True North Study - a clinical research study. Talk to your doctor or call Clinical Research Professionals (Julie Zoll) at 636-220-1200.

Phase N/A

GA28949: Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy (Induction of Remission) And Safety Of Etrolizumab Compared With Adalimumab And Placebo In Patients With Moderate To Severe Ulcerative Colitis Who Are Naïve to TNF Inhibitors.

Phase N/A

000174 : A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 4g Extended Release Granules (Sachet) for the Induction of Clinical and Endoscopic Remission in Active, Mild to Moderate Ulcerative Colitis.

Phase N/A

000175 : A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 2g Extended Release Granules (Sachet) for Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis.

Phase N/A

Inflammatory bowel diseases, including ulcerative colitis, are chronic relapsing disorders characterized by destructive inflammation and epithelial injury in the gastrointestinal tract. This study will evaluate the efficacy of intravenous (IV) ustekinumab in inducing clinical remission in subjects with moderately to severely active ulcerative colitis.

Phase N/A

Have you been diagnosed with ulcerative colitis? Are you still having symptoms while receiving treatment? If so, you may be able to take part in the True North Study. The True North Study is a clinical research study assessing an investigational medication (a potential new medication that is under development) ...

Phase N/A

This is a Phase 1b multicenter, randomized, double-blind, placebo-controlled multiple dose study designed to evaluate the safety and tolerability of SER-287, and to evaluate the microbiome alterations and pharmacodynamics associated with 2 dosing regimens of SER-287 in adult subjects with mild-to-moderate ulcerative colitis (UC).

Phase